HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.

2nd Edition of International Cancer Research Conference

March 19-21, 2026 | Singapore

March 19 -21, 2026 | Singapore

Acute Myeloid Leukemia

Acute Myeloid Leukemia

Acute Myeloid Leukemia (AML) is a rapid-progressing hematologic malignancy characterized by the uncontrolled proliferation of immature myeloid cells. Current cancer research focuses on understanding the genetic and molecular basis of AML to develop targeted therapies. Advances in genomics have identified mutations in genes such as FLT3, NPM1, and DNMT3A, providing insights into disease pathogenesis and potential therapeutic targets. Novel treatments, including FLT3 inhibitors and immune-based therapies like monoclonal antibodies and CAR-T cells, are under investigation. Additionally, researchers are exploring the role of the bone marrow microenvironment in AML progression and resistance to therapy, aiming to improve patient outcomes through personalized medicine.

Committee Members
Speaker at International Cancer Research Conference - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Cancer Research Conference - Anyou Wang

Anyou Wang

DIFIBER LLC, United States
Speaker at Oncology Conferences - Michael Thompson

Michael Thompson

University of Toronto, Canada
Cancer Research 2026 Speakers
Speaker at Cancer Research Conferences - Can Küçük

Can Küçük

Dokuz Eylul University, Turkey
Speaker at International Cancer Research Conference - Nadia Leney Olazo Marquez

Nadia Leney Olazo Marquez

Benemérita Universidad Autónoma de Puebla, Mexico
Speaker at International Cancer Research Conference - Liu Ying

Liu Ying

Shanghai University, China
Speaker at International Cancer Research Conference - Ratan Kumar Sarkar

Ratan Kumar Sarkar

Independent Researcher, India

Submit your abstract Today

Watsapp